New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Odisha’s heritage extends far beyond its celebrated temples, royal monuments and archaeological remains. It…
Bhubaneswar: With a focus on aligning youth skills with emerging employment opportunities, Odisha is undertaking…
Bhubaneswar: Odisha is set to take another major step towards strengthening its position on the…
Bhubaneswar: Odisha is looking to make its irrigation systems more efficient and responsive to farmers’…
Bhubaneswar: Odisha Police has reported a broad improvement in its law-and-order and security operations over…
Amstelveen, Netherlands: The Indian Women’s Hockey Team began their FIH Hockey World Cup Belgium &…
